nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—Pneumonia aspiration—Vandetanib—thyroid cancer	0.138	0.279	CcSEcCtD
Ethanolamine Oleate—FABP4—saliva-secreting gland—thyroid cancer	0.0869	0.195	CbGeAlD
Ethanolamine Oleate—FABP4—trachea—thyroid cancer	0.067	0.15	CbGeAlD
Ethanolamine Oleate—FABP5—thyroid gland—thyroid cancer	0.0567	0.127	CbGeAlD
Ethanolamine Oleate—FABP4—thyroid gland—thyroid cancer	0.053	0.119	CbGeAlD
Ethanolamine Oleate—FABP5—head—thyroid cancer	0.0503	0.113	CbGeAlD
Ethanolamine Oleate—FABP4—head—thyroid cancer	0.047	0.106	CbGeAlD
Ethanolamine Oleate—FABP5—lymph node—thyroid cancer	0.0352	0.0791	CbGeAlD
Ethanolamine Oleate—FABP4—lymph node—thyroid cancer	0.0329	0.0739	CbGeAlD
Ethanolamine Oleate—Pleural effusion—Sorafenib—thyroid cancer	0.0264	0.0536	CcSEcCtD
Ethanolamine Oleate—FABP5—Idarubicin—Epirubicin—thyroid cancer	0.0246	0.519	CbGdCrCtD
Ethanolamine Oleate—FABP5—Idarubicin—Doxorubicin—thyroid cancer	0.0228	0.481	CbGdCrCtD
Ethanolamine Oleate—Oesophageal ulcer—Epirubicin—thyroid cancer	0.0205	0.0416	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Doxorubicin—thyroid cancer	0.019	0.0384	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Epirubicin—thyroid cancer	0.0186	0.0376	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Doxorubicin—thyroid cancer	0.0172	0.0348	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Vandetanib—thyroid cancer	0.0169	0.0342	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Sorafenib—thyroid cancer	0.0159	0.0323	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Epirubicin—thyroid cancer	0.0127	0.0258	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Doxorubicin—thyroid cancer	0.0118	0.0239	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Sorafenib—thyroid cancer	0.0114	0.0231	CcSEcCtD
Ethanolamine Oleate—Chest pain—Vandetanib—thyroid cancer	0.0112	0.0226	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Epirubicin—thyroid cancer	0.00977	0.0198	CcSEcCtD
Ethanolamine Oleate—Necrosis—Epirubicin—thyroid cancer	0.00954	0.0193	CcSEcCtD
Ethanolamine Oleate—Abscess—Epirubicin—thyroid cancer	0.00946	0.0192	CcSEcCtD
Ethanolamine Oleate—Pain—Vandetanib—thyroid cancer	0.00916	0.0186	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Doxorubicin—thyroid cancer	0.00904	0.0183	CcSEcCtD
Ethanolamine Oleate—Necrosis—Doxorubicin—thyroid cancer	0.00882	0.0179	CcSEcCtD
Ethanolamine Oleate—Abscess—Doxorubicin—thyroid cancer	0.00875	0.0177	CcSEcCtD
Ethanolamine Oleate—CYP2E1—thyroid gland—thyroid cancer	0.00868	0.0195	CbGeAlD
Ethanolamine Oleate—Body temperature increased—Vandetanib—thyroid cancer	0.00847	0.0172	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Epirubicin—thyroid cancer	0.00812	0.0165	CcSEcCtD
Ethanolamine Oleate—Ulcer—Epirubicin—thyroid cancer	0.00791	0.016	CcSEcCtD
Ethanolamine Oleate—CYP2E1—head—thyroid cancer	0.0077	0.0173	CbGeAlD
Ethanolamine Oleate—Lacrimation increased—Doxorubicin—thyroid cancer	0.00752	0.0152	CcSEcCtD
Ethanolamine Oleate—Ulcer—Doxorubicin—thyroid cancer	0.00732	0.0148	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Sorafenib—thyroid cancer	0.00723	0.0146	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Epirubicin—thyroid cancer	0.00684	0.0139	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Doxorubicin—thyroid cancer	0.00633	0.0128	CcSEcCtD
Ethanolamine Oleate—Pain—Sorafenib—thyroid cancer	0.00618	0.0125	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Epirubicin—thyroid cancer	0.00589	0.0119	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Sorafenib—thyroid cancer	0.00571	0.0116	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Doxorubicin—thyroid cancer	0.00545	0.011	CcSEcCtD
Ethanolamine Oleate—Dihomo-gamma-linolenic acid—PTGS2—thyroid cancer	0.00516	1	CrCbGaD
Ethanolamine Oleate—Pneumonia—Epirubicin—thyroid cancer	0.00421	0.00853	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Doxorubicin—thyroid cancer	0.0039	0.00789	CcSEcCtD
Ethanolamine Oleate—Chest pain—Epirubicin—thyroid cancer	0.00279	0.00564	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Epirubicin—thyroid cancer	0.00267	0.00541	CcSEcCtD
Ethanolamine Oleate—Chest pain—Doxorubicin—thyroid cancer	0.00258	0.00522	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00247	0.005	CcSEcCtD
Ethanolamine Oleate—Pain—Epirubicin—thyroid cancer	0.00228	0.00463	CcSEcCtD
Ethanolamine Oleate—Pain—Doxorubicin—thyroid cancer	0.00211	0.00428	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Epirubicin—thyroid cancer	0.00211	0.00428	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Doxorubicin—thyroid cancer	0.00195	0.00396	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CDK1—thyroid cancer	0.000882	0.107	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—RXRA—thyroid cancer	0.000759	0.0924	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000608	0.0741	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—PPARG—thyroid cancer	0.000479	0.0583	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000424	0.0516	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CCND1—thyroid cancer	0.000367	0.0448	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—PTEN—thyroid cancer	0.000355	0.0432	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PRKAR1A—thyroid cancer	0.000301	0.0367	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—MINPP1—thyroid cancer	0.000293	0.0357	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NDUFA13—thyroid cancer	0.000249	0.0303	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TP53—thyroid cancer	0.000242	0.0295	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CHST14—thyroid cancer	0.000234	0.0285	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—IFNA2—thyroid cancer	0.000199	0.0243	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HPGD—thyroid cancer	0.000189	0.023	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CDK1—thyroid cancer	0.000185	0.0225	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—RXRA—thyroid cancer	0.000171	0.0209	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000153	0.0187	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CHST14—thyroid cancer	0.000149	0.0181	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000133	0.0162	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TPR—thyroid cancer	0.000108	0.0132	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—PPARG—thyroid cancer	0.000108	0.0132	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PRKAR1A—thyroid cancer	0.000107	0.013	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000102	0.0124	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000101	0.0124	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.67e-05	0.0118	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.27e-05	0.0101	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLC5A5—thyroid cancer	8.12e-05	0.00989	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.61e-05	0.00927	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—NRAS—thyroid cancer	7.44e-05	0.00906	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—RXRA—thyroid cancer	6.82e-05	0.00831	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.63e-05	0.00808	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—NRAS—thyroid cancer	6.63e-05	0.00807	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—KRAS—thyroid cancer	6.4e-05	0.0078	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—KRAS—thyroid cancer	5.7e-05	0.00695	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—TP53—thyroid cancer	5.69e-05	0.00693	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—HRAS—thyroid cancer	5.44e-05	0.00663	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—HRAS—thyroid cancer	4.85e-05	0.00591	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—AKT1—thyroid cancer	4.8e-05	0.00585	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—RXRA—thyroid cancer	4.39e-05	0.00535	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PPARG—thyroid cancer	4.31e-05	0.00525	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—AKT1—thyroid cancer	4.28e-05	0.00521	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTGS2—thyroid cancer	3.39e-05	0.00413	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—MINPP1—thyroid cancer	3.23e-05	0.00393	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTEN—thyroid cancer	2.95e-05	0.0036	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NDUFA13—thyroid cancer	2.74e-05	0.00334	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CHST14—thyroid cancer	2.58e-05	0.00314	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HPGD—thyroid cancer	2.08e-05	0.00253	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AKT1—thyroid cancer	1.7e-05	0.00207	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TPR—thyroid cancer	1.19e-05	0.00145	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.17e-05	0.00143	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC5A5—thyroid cancer	8.94e-06	0.00109	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—RXRA—thyroid cancer	7.51e-06	0.000915	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PPARG—thyroid cancer	4.74e-06	0.000578	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTGS2—thyroid cancer	3.73e-06	0.000454	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTEN—thyroid cancer	3.25e-06	0.000396	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AKT1—thyroid cancer	1.87e-06	0.000228	CbGpPWpGaD
